Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments

7 organizations filed 7 public comments on Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments, at the Food and Drug Administration. The comment window closed 55d ago.

Abstract

The Food and Drug Administration (FDA, the Agency, or we) is proposing to amend the drug establishment registration and drug listing requirements with respect to establishments engaged in distributed manufacturing and foreign drug establishments. This action, if finalized, will provide a pathway for a distributed manufacturing establishment that manufactures drugs at multiple different physical locations to register as a single drug manufacturing establishment and align drug establishment registration and drug listing regulations applicable to foreign drug establishments with statutory changes made by the Preparing for and Responding to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act).

Commenters (7)

• Alliance for Regenerative Medicinetrade assoc.

  1 filing · confidence 85%
• America First Policy Institutetrade assoc.

  1 filing · confidence 85%
• American Society of Ophthalmic Traumatrade assoc.

  1 filing · confidence 85%
• Association for Accessible Medicinestrade assoc.

  1 filing · confidence 97%
• Compressed Gas Associationtrade assoc.

  1 filing · confidence 85%
• DEKA Research and Development Corporationunverified attribution

  1 filing · confidence 70%
• Siemens Corporationunverified attribution

  1 filing · confidence 70%